Download Document

Document related concepts

Polysubstance dependence wikipedia , lookup

Effects of long-term benzodiazepine use wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Neuropharmacology wikipedia , lookup

Serotonin syndrome wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Psychopharmacology wikipedia , lookup

Transcript
Management
of Anxiety
Disorders
Anxiety and Anxiety disorders

Anxiety: subjective experience of fear and it’s
physical manifestations (autonomic symptoms).

It is important for clinicians to be able to distinguish
normal anxiety from pathological anxiety.

Anxiety disorders are caused by a combination of
genetic, environmental, biological and
psychosocial factors.

Associated with neurotransmitter imbalances,
including increase activity of norepinephrine and
decrease activity of GABA and Serotonin.
Normal vs pathological anxiety
NORMAL
• Situational
• In response to
existent threat
• Temporary “short
duration”
• common
PATHOLOGICAL
• Chronic “recurrent
course”.
• No real source of fear or
excess of provoking fear.
• Multiple symptoms
affecting daily life.
Anxiety and Anxiety disorders

Panic Disorder (PD) with/without Agoraphobia

Phobic Disorder (social, specific)

Obsessive- Compulsive Disorder (OCD)

Post-traumatic Stress Disorder (PTSD)

Acute Stress Disorder (ASD)

Generalized Anxiety Disorder (GAD)

Anxiety disorder secondary to general medical condition

Substance-induced anxiety disorder
Management of Anxiety in
general :
Pharmacotherapy
Psychotherapy
Pharmacotherapy
Anti-depressants:



Selective Serotonin Reuptake Inhibitors (SSRI)
Tricyclic Antidepressatns (TCA)
Monoamine Oxidase Inhibitors ( MAOI)
Atypical anti-depressants
Anxiolytics:



Benzodiazepines
Buspirone
Beta blockers
Anti-convulsants
Psychotherapies




Supportive psychotherapy
Cognitive behavioral therapy
Systematic desensitization
Exposure and response prevention
1- Management of Panic Disorder
 Pharmacotherapy
 SSRI
•The long-term treatment is SSRIs, especially paroxetine and sertaline.
•Typically take 2-4 weeks to become effective and higher doses are
required more than for depression).
•Always start SSRIs at low dose and increase slowly because It can
have side effects that may initially worsen anxiety.

Benzodiazepines
Effective immediately but are best used temporarily because of their risk of
causing tolerance and dependency.

Other Antidepressants (clomipramine, imipramine)
may be used

Treatment should continue for at least 8-12 months, as
relapse is common after discontinuation of therapy.
 Psychotherapy
1.
2.
3.
4.
 For
Relaxation training
Biofeedback
Cognitive therapy
Insight-Oriented psychotherapy
Agoraphobia when the coexisting
panic disorder is treated usually it resolves.
2- Management of Specific Phobia
 Pharmacotherapy


Has not been found effective.
A short course of benzodiazepines or beta
blockers may be used during desensitization to help
control autonomic symptoms.
 Psychotherapy
1.
Behavior therapy (most effective)
2.
Systemic desensitization

Gradual exposure to the feared object or situation with
learning the patient relaxation techniques.
3-Management of Social Phobia
 Pharmacotherapy
 SSRI
Paroxetine is FDA approved for the treatment of
social anxiety disorder.

Beta blockers
Used to control symptoms of performance
anxiety.
 Psychotherapy
1.
2.
Cognitive therapy
Behavioral therapy
4- Management of OCD
 Pharmacotherapy
 SSRI
 The first line of treatment.
 Higher than normal doses may be required to
be effective.
 Tricyclic
antidepressants
 Psychotherapy
1. Behavioral therapy
-As effective as pharmacotherapy.
-Best results when used with pharmacotherapy
simultaneously.
2.Exposure
and Response Prevention (ERP)
Involves exposure to the ritual-eliciting stimulus and
prevention of the relieving compulsion. (e.g., the patient
must touch the dirty floor without washing his or her
hands).
3.Relaxation

techniques
Last resort
Electroconvulsive therapy (ECT)
Surgery (cingulotomy) … lesioning of ant. cingulate gyrus
which is part of limbic system
5- Management of PTSD & ASD
 Pharmacotherapy

to reduce symptoms :
Antidepressants
SSRIs, TCA, MAOIs

Anticonvulsants
(For flashbacks and nightmares.)
 Psychotherapy
1.
2.
3.
4.

cognitive-behavioral, support, psychodynamic
therapy
Relaxation training
Support group, family therapy
Eye Movement Desensitization and Reprocessing
(EMDR)
Addictive medications (benzodiazepines) should be
avoided in the treatment of PTSD because of the
high rate of substance abuse in these patients.
6-Management of GAD
 Pharmacotherapy
 Antidepressants
SSRIs, Venlafaxine(snri)

Anxiolytics: Benzodiazepines, Buspirone
 Psychotherapy
Cognitive-behavioral therapy
 The
most effective treatment
approach is a combination of
psychotherapy and pharmacotherapy
In Details:
Pharmacotherapy
 Anti-depressants

Selective Serotonin Reuptake
Inhibitors (SSRI)

Tricyclic Antidepressatns (TCA)

Monoamine Oxidase Inhibitors (
MAOI)
MOA:
SSRIs inhibits presynaptic serotonin pumps that
take up serotonin, which will increase
availability in synaptic cleft.
 The
most commonly prescribed antidepressant due to:



Low incidence of side effects, most of which resolve
with time.
No food restrictions.
Safer in overdose.

Fluoxetine:




Sertaline:



Longest half life with active metabolites; therefore, no
need to taper.
Safe in pregnancy, approved for use in children.
Can elevate levels of neuroleptics, leading to increase
side effects.
Highest risk for GI disturbances.
Very few drug interactions.
Proxetine:



High protein bound, leading to several drug interactions.
More anticholinergic effects like sedation, constipation,
weight gain.
Short half-life leading to withdrawal phenomena if not
taken consistently

Fluvoxamine:



Citalopram:



Nausea and vomiting more common.
Lots of drug interactions.
Fewest drug interactions.
Possibly fewer sexual side effects.
Escitalopram:


Levo-enantiomer of citalopram; similar
efficacy, fewer side effects.
More expensive than citalopram.
Indications :







Depression in children above 6 years (fluoxetine) and
adults
Premenstrual dysphoric disorder (sertraline)
Impulse control disorder
Hypochondriasis and body dysmorphic disorder
(fluoxetine)
Premature ejaculation (fluoxetine/sertraline)
Autism and ADHD/obesity/eating disorder/migraine/IBS
In anxiety disorders:



Panic disorder  paroxetine and sertraline
OCD  all are effective. But if a child has OCD our
first choice will be sertraline then fluvoxamine and
finally citalopram.
Agoraphobia, social anxiety, Posttraumatic stress
disorder (PTSD),Acute stress disorder  paroxetine
 Sexual


decrease interest, anorgasmia, delayed ejaculation.
These typically do not resolve in a few weeks.
Treated by augmenting the regimen with buproprion,
changing to non- SSRI or by adding another medications
like sildenafil for men.
 GI


dysfunction (25-30%):
disturbances:
mostly nausea and diarrhea
giving food can help.
 Insomnia:


also vivid dreams,
often resolves over time
 Headache.
 Anorexia,
weight loss.
 Restlessness
 An
akathisia-like state has been reported at
initiation and termination of SSRIs.
Benzodiazepine or B-blocker or
anticholinergic
 Seizure
 Rate
of 0.2%
 Slighty lower than TCAs.
•
Serotonin syndrome
•
Caused by taking 2 drugs, both of which increase
serotonin  too much serotonin in the brain; like
when used with MAOI
•
Symptoms: nausea, diarrhea, palpitations, chills,
rigor, restlessness, confusion and lethargy,
Hyperreflexia.
•
Drugs that increase the serotonin maybe found
over the counter cold remedies, possibly 
serotonin syndrome.
•
Management of Serotonin Syndrome








stop the drug
ABC
Gastric lavage if overdose
IV fluid and NaHCO3
Benzodiazepines (calm the pt, muscle relaxant and prevent
seizure)
B-blocker
Mirtazapine (Nassa)
ECT
 SSRIs
increase suicidal thinking and
behavior, this is most documented in
children and adolescents but may be
accurate for adults as well.
 You should give a patient an adequate
trial of antidepressants, usually between 1
and 2 months at full dose, before
considering changing medication.
 MOA:



Inhibits the reuptake of norepinephrine and
serotonin, which leads to increase availability of
monoamines in the synapse.
Because of the long half lives, most are dosed
once daily.
They are rarely used as first-line agents
because they have a higher incidence of side
effects, require greater monitoring of dosing,
and can be lethal in overdose.
 Tertiary
amines: (highly anticholinergic, more
sedating, greater lethality in overdose)

Amitriptyline


Imipramine



Has intramuscular form
Useful in enuresis and panic disorders
Clomipramine


Useful in chronic pain, migraines, and insomnia.
Most serotonin specificm useful in treatment of OCD.
Doxepin


Useful in treating chronic pain
Emerging use as a sleep aid in low doses

Secondary amines: (metabolites of tertiary
amines)

Nortriptyline
Least likely to cause othostatic hypotension
 Useful therapeutic blood levels
 Useful in treating chronic pain


Desipramine
More activating; least sedating
 Least anticholinergic


Indications:
 Depression







Anxiety disorders
OCD clomipramine
PTSD imipramine and doxepin
Pain syndrome
Nocturnal enuresis
Eating disorder
Attention Deficit Hyperactive Disorder
Insomnia
Compulsive behaviors in children

Anti-histaminic properties (sedation)

Anti-adrenergic properties (arrhythmias, tachycardia, postural
hypotension)

Anticholinergic effects ( dry mouth, constipation, urinary
retention, blurred vision)

Weight gain

Major complications 3Cs (Convulsion, Coma, Cardiotoxicity)

Lethal in overdose

Seizures (0.3%)
 MOA


Prevent the inactivation of biogenic amines
such as norepinephrine, serotonin, dopamine
and tyramine.
Examples of MAOIs
Phenelzine, tranylcypromine,
isocarboxazid.

Uses

Depression, panic disorder, posttraumatic
stress disorder, acute stress disorder.




Serotonin syndrome if taken with SSRI
Hypertensive crisis when taken with
tyramine-rich foods or sympathomimetics.
Postural hypotension, drowsiness, weight
gain
Sexual dysfunction, dry mouth, sleep
dysfunction
 Anxiolytics

Benzodiazepines

Buspirone

Beta blockers
 Benzodiazepines
 MOA





Works by potentiating the effects of
gammaamino-butyric acid GABA.
First-line anxiolytics.
Many patients become dependent and
addicted.
Choice of BDZs is based on time to onset of
action, duration of action, and method of
metabolism.
Benzodiazepines should not be used as sole
treatment for chronic anxiety.
 Benzodiazepines
 Long

acting (half-life >20 hours)
Diazepam
 Rapid
onset.
 Used during detoxification from alcohol or
sedative-hypnotic-anxiolyticx and for seizure.

Clonazepam
 Treatment
of anxiety, including panic attacks.
 Avoid with renal dysfunction; longer half-life
allows for once daily dosing.
Diazepam
Cautions:
Contraindications:
- Respiratory disease
- Respiratory depression
- Muscle weakness
- Myasthenia Gravis
- Unstable Myasthenia Gravis
- History of drugs and alcohol abuse
- Pulmonary insufficiency
- Marked personality disorder
- Acute porphyria
- Sleep apnea syndrome
 Benzodiazepines
 Intermediate
hours)

Alprazolam



Treatment of panic attacks, alcohol and sedative-hypnoticanxiolytic detoxification, agitation
Oxazepam



Treatment of anxiety; including panic attacks
Short onset of action leads to euphoria, high abuse potential.
Lorazepam


acting (half-life 6-20
alcohol and sedative-hypnotic-anxiolytic detoxification
Not metabolized by the liver.
Temazepam


Decreasingly used for treatment of insomnia due to
dependence.
Not metabolized by the liver.
 Benzodiazepines
 Short

acting (half-life < 6 hours)
Triazolam
 Treatment
of insomnia.
 Primarily used in medical and surgical settings.

Midazolam
 Primarily
used in medical and surgical settings.
 Benzodiazepines






Side effects:
Drowsiness
Impairment of intellectual function*
Reduced motor coordination (careful in
elderly)
Anterograde amnesia
Withdrawal can be life threatening and
causes seizure
Toxicity with alcohol: Respiratory depression
 Benzodiazepines

Special cases

Hepatic Impairment


Renal impairment


patients with renal impairment have increased cerebral sensitivity to
these drugs.
Pregnancy





benzodiazepines can precipitate Coma if used in hepatic impairment ,
so use benzodiazepines that are not metabolized by the liver:
Lorazepam, Oxazepam, Temazepam . ( L.O.T )
There is a risk of neonatal withdrawal symptoms when these drugs are used
during pregnancy.
So avoid regular use and use only if there is a clear indication such as seizure
control
high doses administrated during late pregnancy or labor may cause
neonatal hypothermia , hypotonia , and respiratory depression .
Teratogenic - especially in the 1st trimester- Cleft palate.
Breast-feeding

should be avoided if possible during breast-feeding.
 Buspirone




The anxiolytic action is at 5HT-1A receptor
(partial agonist)
It has a slower onset of action than BDZs
(takes 1-2 weeks for effect).
Not considered as effective as other options,
and so it is often used in combination with
another agent (SSRI), for treatment of anxiety.
It idoes not potentiate the CNS depression of
alcohol (useful in alcoholics), and has a low
potential for abuse/addiction.
 Buspirone






Side effects:
Nausea
Dizziness
Headache
Nervousness
Excitement
Rarely ……
dry mouth , tachycardia , chest pain , drowsiness ,
confusion , seizure , fatigue and sweating
 Buspirone
 Special

Hepatic Impairment



Reduce dose in mild and moderate disease
Avoid it in severe disease
Renal impairment



cases
Reduce dose in mild and moderate cases
Avoid it if eGFR less than 20 ml/min/1.73 m2
Pregnancy and breastfeeding
 avoid
this drug.
 B-blockers (propranolol)
 Useful
for treating the autonomic effects
of panic attacks or performance anxiety,
such as palpitations, sweating and
tachycardia.
 Can
also be used for treating Akathisia
(side effect of typical antipsychotics).
 Other Medications

Venlafaxine (atypical antidepressant)




It is a SNRI, so it increases serotonin and
norepinephrine availability in the synaptic cleft.
Useful in treating generalized anxiety disorder,
panic disorder and social anxiety.
Main side effect: increase the blood pressure.
Topiramate (An anticonvulsant)



Blocks sodium channels, inhibits glutamate and
enhances GABA
One of the new generations of mood stabilizers
Useful in treating the flashbacks and nightmares
associated with Posttraumatic stress disorder.
In Details: Psychotherapy
Supportive psychotherapy

Supportive psychotherapy is commonly used
as an adjuvant treatment even in the most
severe mental disorders.

Purpose is to help the patient feel safe during
difficult times.

It is not insight-oriented but instead focuses on
empathy, understanding, and education.

Helps build up the patient’s healthy defenses
and lessens the anxiety through specific
techniques such as reassurance, advice and
encouragement.
Supportive psychotherapy

Techniques of supportive psychotherapy:







Praising (reinforcing positive behavior).
Reassurance.
Normalizing (reassure the patient that their
thoughts and feelings are not unusual or
pathological).
Encouragement.
Reframing.
Advice and teaching.
Careful use of language.
Cognitive-Behavioral Therapy
(CBT)



CBT combines ideas from cognitive therapy and
behavior therapy.
Cognitive therapy: seeks to correct faulty
assumptions and negative feelings that
exacerbate psychiatric symptoms. The patient is
taught to identify maladaptive thoughts and
replace them with positive ones.
Behavior therapy: helps the patient to change
their behaviors that contribute to their symptoms. It
can be used to extinguish maladaptive behaviors
by replacing them with healthy alternatives.
Cognitive-Behavioral Therapy
(CBT)





Treatment follows a protocol or manual with
homework assignments between therapy sessions.
During therapy sessions, the patient and the
therapist set an agenda, review homework, and
challenge cognitive distortions.
The patient learns how his behavior is influenced
by his thoughts.
Treatment is usually brief and may last from 6
weeks to 6 months.
Research has shown than CBT is effective for many
psychiatric illnesses, including depression, anxiety,
and substance abuse.
Systematic desensitization



Used mostly to help effectively overcome specific
phobias.
When persons experience such phobias (for
example fears of heights, dogs, snakes, closed
spaces, etc.), they tend to avoid the feared
stimuli; this avoidance, in turn, can temporarily
reduce anxiety but is not necessarily an adaptive
way of coping with it. In this regard, patients'
avoidance behaviors can become reinforced.
The goal of systematic desensitization thus, is to
overcome avoidance by gradually exposing
patients to the phobic stimulus, until that stimulus
can be tolerated.
Exposure and response
prevention





Used mostly in the management of obsessive–
compulsive disorder.
Helps to resist carrying out compulsions.
Therapeutic effect is achieved as subjects
confront their fears and discontinue their escape
response.
Uses some short-term anxiety, this facilitates longterm reduction in obsessive and compulsive
symptoms.
Relaxation techniques are employed to help the
patient manage the anxiety that occurs when the
compulsion is prevented.
Exposure and response
prevention



The Exposure in ERP refers to confronting the
thoughts, images, objects and situations that
make a person with OCD anxious.
The Response Prevention in ERP refers to
making a choice not to do a compulsive
behavior after coming into contact with the
things that make a person with OCD anxious the response is delayed or prevented The natural drop in anxiety that happens
when you stay “exposed” and “prevent” the
“response” is called habituation.
summary

Panic disorder:
-In acute case : short term course BDZ
-Maintenance :SSRI (paroxetine/ sertraline)

OCD:
-Pharmacotherapy: high dose SSRI (fluvoxamine), TCA (clomipramine)
-Behavioral therapy: exposure and response prevention
-For resistant cases: ECT/ Cingulotomy

PTSD:
-Pharmacotherapy: TCA (imipramine, doxepin), SSRI, MAOI/
anticonvulsants
-Psychotherapy: Relaxation and family and group therapy

GAD:
-Pharmacotherapy: SSRI, Buspirone, BDZ, venlafaxine
-Psychotherapy and behavioral therapy
Thank you 